KR101556700B1 - 트라마돌 및 콕시브의 공결정의 약학적 조성물 - Google Patents

트라마돌 및 콕시브의 공결정의 약학적 조성물 Download PDF

Info

Publication number
KR101556700B1
KR101556700B1 KR1020127033847A KR20127033847A KR101556700B1 KR 101556700 B1 KR101556700 B1 KR 101556700B1 KR 1020127033847 A KR1020127033847 A KR 1020127033847A KR 20127033847 A KR20127033847 A KR 20127033847A KR 101556700 B1 KR101556700 B1 KR 101556700B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
pain
tramadol
celecoxib
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127033847A
Other languages
English (en)
Korean (ko)
Other versions
KR20130093015A (ko
Inventor
루이스 솔레르 란자니
알버트 팔리벤느 알데아
Original Assignee
라보라토리오스 델 드라. 에스테브.에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라보라토리오스 델 드라. 에스테브.에스.에이. filed Critical 라보라토리오스 델 드라. 에스테브.에스.에이.
Publication of KR20130093015A publication Critical patent/KR20130093015A/ko
Application granted granted Critical
Publication of KR101556700B1 publication Critical patent/KR101556700B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020127033847A 2010-06-04 2011-06-03 트라마돌 및 콕시브의 공결정의 약학적 조성물 Active KR101556700B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10384002.1 2010-06-04
EP10384002A EP2392319A1 (en) 2010-06-04 2010-06-04 Pharmaceutical compositions of co-crystals of tramadol and coxibs
PCT/EP2011/002749 WO2011151080A1 (en) 2010-06-04 2011-06-03 Pharmaceutical compositions of co-crystals of tramadol and coxibs

Publications (2)

Publication Number Publication Date
KR20130093015A KR20130093015A (ko) 2013-08-21
KR101556700B1 true KR101556700B1 (ko) 2015-10-01

Family

ID=42358396

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127033847A Active KR101556700B1 (ko) 2010-06-04 2011-06-03 트라마돌 및 콕시브의 공결정의 약학적 조성물

Country Status (34)

Country Link
US (1) US8846744B2 (enExample)
EP (3) EP2392319A1 (enExample)
JP (1) JP5800016B2 (enExample)
KR (1) KR101556700B1 (enExample)
CN (1) CN102946871B (enExample)
AR (1) AR081774A1 (enExample)
AU (1) AU2011260608B2 (enExample)
BR (1) BR112012030704A2 (enExample)
CA (1) CA2798090C (enExample)
CO (1) CO6660469A2 (enExample)
CY (1) CY1118813T1 (enExample)
DK (1) DK2575778T3 (enExample)
EC (1) ECSP13012368A (enExample)
ES (1) ES2622192T3 (enExample)
HR (1) HRP20170594T1 (enExample)
HU (1) HUE033999T2 (enExample)
IL (1) IL222731A (enExample)
LT (1) LT2575778T (enExample)
MX (1) MX351507B (enExample)
MY (1) MY156859A (enExample)
NZ (1) NZ603457A (enExample)
PH (1) PH12012502171A1 (enExample)
PL (1) PL2575778T3 (enExample)
PT (1) PT2575778T (enExample)
RS (1) RS55878B1 (enExample)
RU (1) RU2567843C2 (enExample)
SG (1) SG185385A1 (enExample)
SI (1) SI2575778T1 (enExample)
SM (1) SMT201700261T1 (enExample)
TN (1) TN2012000515A1 (enExample)
TW (1) TWI508722B (enExample)
UA (1) UA109661C2 (enExample)
WO (1) WO2011151080A1 (enExample)
ZA (1) ZA201208767B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120089287A (ko) * 2009-10-16 2012-08-09 라보라토리오스 델 드라. 에스테브.에스.에이. 통증 치료에 있어서 트라마돌 및 셀레콕시브를 포함하는 조성물

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) * 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
WO2014138881A1 (en) * 2013-03-12 2014-09-18 Patheon, Inc. Drug delivery system
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
WO2015166473A1 (en) 2014-05-01 2015-11-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
PL3137057T3 (pl) * 2014-05-01 2021-04-06 Sun Pharmaceutical Industries Ltd Kompozycje ciekłe metforminy o przedłużonym uwalnianiu
EP3174515A4 (en) 2014-07-30 2018-03-21 Sun Pharmaceutical Industries Limited Dual-chamber pack
WO2016046693A1 (en) * 2014-09-25 2016-03-31 Nathwani Sandeep Vinodkumar A co-processed pharmaceutical excipient
CN104276960B (zh) * 2014-09-26 2016-09-28 安徽省逸欣铭医药科技有限公司 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
WO2018031577A1 (en) * 2016-08-09 2018-02-15 Autotelic Llc Fixed dose combination for pain relief without edema
DE102016012746A1 (de) 2016-10-25 2018-04-26 WindplusSonne GmbH Vorprodukte zur Herstellung von porösen, mineralischen Leichtbaumaterialien, Verfahren zur Herstellung von porösen, mineralischen Leichtbaumaterialien und ihre Verwendung
US10080762B2 (en) 2016-12-14 2018-09-25 Druggability Technologies Ip Holdco Limited Pharmaceutical composition containing Celecoxib
CN107595792A (zh) * 2017-11-06 2018-01-19 刘丽 一种盐酸他喷他多塞来昔布片剂及其制备方法
CN110101673A (zh) * 2019-05-07 2019-08-09 安徽金太阳生化药业有限公司 一种盐酸曲马多分散片的制备方法
MX2021013123A (es) * 2019-05-14 2021-11-18 Esteve Pharmaceuticals Sa Uso de co-cristales de tramadol y celecoxib para el tratamiento del dolor mientras se reduce la responsabilidad por abuso de tramadol.
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途
CN115251264B (zh) * 2022-08-05 2023-11-21 齐鲁工业大学 含桑叶提取物的共结晶粉末功能性饮料及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010043412A1 (en) * 2008-10-17 2010-04-22 Laboratorios Del Dr. Esteve, S.A. Co-crystals of tramadol and nsaids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1040945A1 (zh) * 1999-03-01 2002-06-28 Ortho-Mcneil Pharmaceutical, Inc. 包含曲马多物质和选择性cox-2抑制剂药物的组合物
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition
DE60325020D1 (de) * 2002-02-19 2009-01-15 Adcock Ingram Ltd Pharmazeutische kombinationen aus meloxicam, codein phosphat und paracetamol
JP2005154334A (ja) * 2003-11-25 2005-06-16 Toa Yakuhin Kk アズレンスルホン酸塩水溶液剤
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
WO2008085674A1 (en) * 2007-01-04 2008-07-17 Transform Pharmaceuticals, Inc. Pharmaceutical compositions comprising celecoxib co-crystals
CN101254180B (zh) * 2008-03-28 2010-11-10 辽宁正鑫药物研究有限公司 一种内容物为半固体组合物的尼莫地平胶囊剂及制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010043412A1 (en) * 2008-10-17 2010-04-22 Laboratorios Del Dr. Esteve, S.A. Co-crystals of tramadol and nsaids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120089287A (ko) * 2009-10-16 2012-08-09 라보라토리오스 델 드라. 에스테브.에스.에이. 통증 치료에 있어서 트라마돌 및 셀레콕시브를 포함하는 조성물
KR101688996B1 (ko) 2009-10-16 2016-12-22 라보라토리오스 델 드라. 에스테브.에스.에이. 통증 치료에 있어서 트라마돌 및 셀레콕시브를 포함하는 조성물

Also Published As

Publication number Publication date
UA109661C2 (uk) 2015-09-25
LT2575778T (lt) 2017-04-10
JP2013530952A (ja) 2013-08-01
SI2575778T1 (sl) 2017-07-31
US20130109659A1 (en) 2013-05-02
SMT201700261T1 (it) 2017-07-18
KR20130093015A (ko) 2013-08-21
CN102946871B (zh) 2019-03-08
DK2575778T3 (en) 2017-04-18
CO6660469A2 (es) 2013-04-30
TW201143760A (en) 2011-12-16
RU2567843C2 (ru) 2015-11-10
PT2575778T (pt) 2017-04-21
TWI508722B (zh) 2015-11-21
CY1118813T1 (el) 2018-03-07
BR112012030704A2 (pt) 2016-09-13
MX2012014087A (es) 2013-02-27
CA2798090C (en) 2017-02-28
ECSP13012368A (es) 2013-01-31
RS55878B1 (sr) 2017-08-31
TN2012000515A1 (en) 2014-04-01
EP2575778A1 (en) 2013-04-10
EP2575778B1 (en) 2017-01-18
SG185385A1 (en) 2012-12-28
EP2392319A1 (en) 2011-12-07
PH12012502171A1 (en) 2016-02-24
CN102946871A (zh) 2013-02-27
RU2012157256A (ru) 2014-07-20
HUE033999T2 (en) 2018-01-29
MY156859A (en) 2016-04-15
AU2011260608B2 (en) 2015-05-07
HRP20170594T1 (hr) 2017-06-16
IL222731A0 (en) 2012-12-31
MX351507B (es) 2017-10-18
PL2575778T3 (pl) 2017-09-29
ZA201208767B (en) 2013-07-31
AR081774A1 (es) 2012-10-17
CA2798090A1 (en) 2011-12-08
AU2011260608A1 (en) 2012-11-22
IL222731A (en) 2016-05-31
NZ603457A (en) 2014-10-31
ES2622192T3 (es) 2017-07-05
JP5800016B2 (ja) 2015-10-28
US8846744B2 (en) 2014-09-30
WO2011151080A1 (en) 2011-12-08
EP3158994A1 (en) 2017-04-26

Similar Documents

Publication Publication Date Title
KR101556700B1 (ko) 트라마돌 및 콕시브의 공결정의 약학적 조성물
WO2007138466A2 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
JP2012514632A (ja) 二段階放出型医薬懸濁剤
TW202038917A (zh) 包含托法替尼或其藥學上可接受的鹽類的延長釋放配方及其製備方法
WO2016075617A1 (en) Fixed dose pharmaceutical formulations of analgesic and anti-spasmodic drugs
RU2662562C2 (ru) Композиция в форме таблеток, содержащая гидрохлорид цинакалцета
CN117529310A (zh) 微粒化的索拉贝隆的组合物及其使用方法
CA2853117C (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
KR101076648B1 (ko) 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
JP6042886B2 (ja) 早漏症治療用の薬学組成物
EP3238713A1 (en) Pharmaceutical compositions of flurbiprofen and tramadol
HK1180981A (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
HK1180982A (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
HK1180982B (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
WO2005016315A1 (en) Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
KR20250101196A (ko) 생체 이용률이 개선된 페노피브레이트를 포함하는 약제학적 조성물
JP2016098230A5 (enExample)
JP2023157789A (ja) グアンファシン含有徐放性製剤
CN105407882A (zh) 包含呈阿戈美拉汀与有机酸的共晶体形式的阿戈美拉汀的药物制剂
TW202214223A (zh) 稠合三環γ-胺基酸衍生物的緩釋藥物製劑及其製備方法
HUE029193T2 (en) Delayed release drug formulations of thiocolchicoside

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121226

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141124

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20141124

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150309

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20150728

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20150923

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20150923

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20190916

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20190916

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20200624

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20230626

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20240624

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20250625

Start annual number: 11

End annual number: 11